GDF3 and metabolic dysfunction-associated steatohepatitis: Consistently, plasma GDF3 levels are significantly elevated and correlated with hepatic pathological features in patients with MASH, offering high diagnostic accuracy for MASH with good sensitivity and specificity (Xiang et al., 2022).